UMESH SHANKARLALJI KANKARIA

    DIN: 08039396

    For latest information about the director, visit MCA.

    UMESH SHANKARLALJI KANKARIA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 08039396. UMESH SHANKARLALJI KANKARIA is/has been associated with 20 companies.

    This is just one director. Ask about the whole track record.

    Ask Prime Research

    Companies Associated With

    Company Designation Date of Appointment
    MAHALUNGE LAND DEVELOPERS LLP Partner 24-Sep-2019
    ATHRVI PROJECT MANAGEMENT LLP Partner 01-Apr-2020
    IGNITE BUILDCON LLP Designated Partner 27-May-2024
    ASHDAN PROJECTS PRIVATE LIMITED Additional Director 01-Mar-2024
    SOLITAIRE METROPOLIS PRIVATE LIMITED Director 29-Dec-2017
    CHORDIA HOLDINGS AND CONSTRUCTION PRIVATE LIMITED Additional Director 02-Mar-2024
    MERCULUS CONSTRUWELL PRIVATE LIMITED Additional Director 05-Apr-2024
    PRAVI CONSTRUWELL PRIVATE LIMITED Director 11-Jun-2024
    CASTLE CREST REAL ESTATE DEVELOPERS PRIVATE LIMITED Director 14-Jun-2024
    PERFECT REALTY PRIVATE LIMITED Additional Director 17-Nov-2023
    KHUBCHANDANI PROPERTIES AND INVESTMENTS PRIVATE LIMITED Additional Director 17-Nov-2023
    ASHDAN BUILDCON PRIVATE LIMITED Additional Director 01-Mar-2024
    ASHDAN LAND DEVELOPERS PRIVATE LIMITED Additional Director 01-Mar-2024
    ASHDAN REALTY PRIVATE LIMITED Additional Director 02-Mar-2024
    MAGNITE PROPERTIES PRIVATE LIMITED Additional Director 01-Mar-2024
    AROSE PROPERTIES PRIVATE LIMITED Additional Director 01-Mar-2024
    BVP REAL ESTATE DEVELOPERS PRIVATE LIMITED Additional Director 01-Mar-2024

    Past Companies Associated With

    Company Designation Date of Appointment Date of Cessation
    MAHALUNGE LAND DEVELOPERS LLP Designated Partner 23-Sep-2019 23-Sep-2019
    D S KULKARNI DEVELOPERS LTD Additional Director 24-Aug-2023 20-Nov-2023
    D S KULKARNI DEVELOPERS LTD Director 21-Nov-2023 06-Mar-2024

    “Assess financial performance of all companies under a director.”

    Ask Prime Research Explore for Sales